Ardelyx (ARDX) Cash & Equivalents Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.98% |
| Dec 31, 2025 | -5.67% |
| Sep 30, 2025 | -14.04% |
| Jun 30, 2025 | -2.17% |
| Mar 31, 2025 | -21.88% |
| Dec 31, 2024 | -18.55% |
| Sep 30, 2024 | -12.54% |
| Jun 30, 2024 | -14.11% |
| Mar 31, 2024 | -17.05% |
| Dec 31, 2023 | -22.89% |
| Sep 30, 2023 | -14.76% |
| Jun 30, 2023 | -20.00% |
| Mar 31, 2023 | 6.42% |
| Dec 31, 2022 | 4.98% |
| Sep 30, 2022 | 0.72% |
| Jun 30, 2022 | -3.44% |
| Mar 31, 2022 | -7.94% |
| Dec 31, 2021 | -0.59% |
| Sep 30, 2021 | -14.03% |
| Jun 30, 2021 | -9.97% |
| Mar 31, 2021 | -13.31% |
| Dec 31, 2020 | -3.18% |
| Sep 30, 2020 | -6.75% |
| Jun 30, 2020 | -6.62% |
| Mar 31, 2020 | 1.50% |
| Dec 31, 2019 | 11.04% |
| Sep 30, 2019 | -3.73% |
| Jun 30, 2019 | -5.32% |
| Mar 31, 2019 | 22.61% |
| Dec 31, 2018 | 18.00% |
| Sep 30, 2018 | 26.10% |
| Jun 30, 2018 | 31.04% |